The association between smoking and breast cancer characteristics and outcome

by Hadar Goldvaser, Omer Gal, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Tzippy Shochat, Aaron Sulkes, Baruch Brenner, Rinat Yerushalmi
Published 2017-09-01

The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States

by Assaf Moore, Ido Stav, Robert B. Den, Noa Gordon, Michal Sarfaty, Victoria Neiman, Eli Rosenbaum, Daniel A. Goldstein
Published 2019-01-01

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics

by Hadar Goldvaser, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Daniel Shepshelovich, Tzippy Shochat, Aaron Sulkes, Baruch Brenner, Rinat Yerushalmi
Published 2016-01-01

Case report: Fatal mesenteric and retroperitoneal serositis after pelvic chemoradiation followed by a single dose of chemotherapy and nivolumab

by Aaron Sulkes, Yulia Kundel, Eran Sadot, Pierre Singer, Victoria Neiman, Liudmila Fridel, Marva Harpak, Hanoch Kashtan, Baruch Brenner
Published 2020-12-01

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer

by Yosef Landman, Salomon Marcello Stemmer, Aaron Sulkes, Victoria Neiman, Tal Granot, Daniel Hendler, Mordechai Reuven Kramer, Karen Gelmon, Rinat Yerushalmi
Published 2019-01-01

Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis.

by Rinat Yerushalmi, Hadar Goldvaser, Aaron Sulkes, Irit Ben-Aharon, Daniel Hendler, Victoria Neiman, Noa Beatrice Ciuraru, Luisa Bonilla, Limor Amit, Alona Zer, Tal Granot, Shulamith Rizel, Salomon M Stemmer
Published 2014-01-01

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock

by Osnat Itzhaki Ben Zadok, MD, MS, Ben Ben-Avraham, MD, Anju Nohria, MD, Katia Orvin, MD, Mithal Nassar, MD, Zaza Iakobishvili, MD, PhD, Victoria Neiman, MD, Hadar Goldvaser, MD, Ran Kornowski, MD, Tuvia Ben Gal, MD
Published 2019-09-01

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random...

by Howard Gurney, Thomas Powles, Asim Amin, Bohuslav Melichar, Camillo Porta, David F McDermott, Toni K Choueiri, Marc-Oliver Grimm, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Hans J Hammers, Saby George, Robert J Motzer, Alain Ravaud, Osvaldo Arén Frontera, Frede Donskov, Philippe Barthélémy, Victoria Neiman, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Raya Leibowitz-Amit, Poul F Geertsen, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir
Published 2020-07-01